Kansas ED Visits Spiked After State Kratom Ban: 121 Cases in Three Weeks

Why it matters

Kansass experience offers the first documented post-ban emergency department surge data in the U.S., giving other states an evidence base for planning withdrawal management capacity before enacting kratom prohibition.

The big picture

Kansas banned 7-hydroxymitragynine and kratom substances as Schedule I drugs effective July 1, 2026 under House Bill 2365. The Kansas Department of Health and Environment monitors emergency department syndromic surveillance data, providing near-real-time insight into the public health consequences of the ban. Similar bans in Tennessee, North Dakota, and others are producing parallel pressures on emergency health systems.

Key findings

• From June 28 through July 18, 2026 — spanning the first three weeks after the Kansas ban — there were 121 suspected kratom-related emergency department visits statewide
• More than 85% of those ED visits involved suspected withdrawal or detox from kratom or 7-OH, not acute overdose
• Prior to the ban, products were sold openly in smoke shops, gas stations, convenience stores and online retailers
• 7-OH products are synthetic concentrates far more potent and addictive than natural kratom leaf
• KDHE and the FDA had jointly issued a public alert about 7-OH risks in September 2025, months before the ban took effect

What they say

The Kansas Substance Use Disorder and Overdose Prevention Program report notes that "7-OH is more addictive than kratom, and using it with alcohol or other sedatives can cause severe respiratory depression and, in some cases, death."

Bottom line

Kansass first three weeks post-ban produced 121 kratom-related ER visits — 85% withdrawal-driven — making clear that bans without treatment infrastructure risk swapping one crisis for another.